Novo Nordisk CEO to face off with Bernie Sanders over 1300% Ozempic markup in U.S. - Fortune
- Novo Nordisk CEO to face off with Bernie Sanders over 1300% Ozempic markup in U.S. Fortune
- Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy Reuters.com
- Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify The Hill
- Bernie Sanders will grill Novo Nordisk's CEO over Ozempic prices Quartz
- Bernie Sanders to grill Novo Nordisk CEO on cost of Ozempic and Wegovy Business Insider